CRISPR Therapeutics AG
Industry: Life Sciences ・ $CRSP on Nasdaq
Insider Sale
+$1,001,187
-6.31%
Shares
Shares Volume: 18,568 Shares
Average Share Price: $53.92
INSIDER
Kulkarni Samarth
Chief Executive Officer (Director)
reported on Feb 19 2025
traded on Feb 18 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 275,595 |
| PURCHASES/SALES 1Y | 0 / 8 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $991,940.09 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 15 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $634,517.17 |
| COMPANY PREVIOUS TRADES |